Quote | Avalo Therapeutics Inc. (NASDAQ:AVTX)
Last: | $10.93 |
---|---|
Change Percent: | 4.34% |
Open: | $11.125 |
Close: | $10.93 |
High: | $11.68 |
Low: | $10.93 |
Volume: | 17,496 |
Last Trade Date Time: | 06/14/2024 03:00:00 am |
News | Avalo Therapeutics Inc. (NASDAQ:AVTX)
WAYNE, Pa. and ROCKVILLE, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will present on the Novel Immunological Mechanisms for Dermatological Disorders Panel being held at...
2024-06-07 04:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Message Board Posts | Avalo Therapeutics Inc. (NASDAQ:AVTX)
Subject | By | Source | When |
---|---|---|---|
Awl416 Thinking this might bounce back in a few months? | GO4AWILDRIDE | investorshub | 06/26/2023 5:18:48 PM |
I concur. This is the third unexpected contender | reena969 | investorshub | 06/26/2023 1:02:32 PM |
Damn | Awl416 | investorshub | 06/26/2023 12:44:27 PM |
$AVTX MomentumIts gaining up | TRADER99 | investorshub | 06/25/2023 5:53:54 PM |
$AVTX The now last trade up | AliasUser1 | investorshub | 06/07/2023 7:49:15 AM |
News, Short Squeeze, Breakout and More Instantly...
Avalo Therapeutics Inc. Company Name:
AVTX Stock Symbol:
NASDAQ Market:
WAYNE, Pa. and ROCKVILLE, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (NASDAQ:AVTX) announced today that Garry A. Neil, M.D....
WAYNE, Pa. and ROCKVILLE, Md., June 17, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, will present on the Novel Immunological Mechanisms for Dermatological Disorders Panel being held at...
2024-06-07 04:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...